Target type: biologicalprocess
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a L-glutamine stimulus. [GO_REF:0000071, GOC:TermGenie, PMID:23185570]
L-glutamine is a non-essential amino acid that plays a crucial role in cellular metabolism. It is involved in a wide range of cellular processes, including protein synthesis, energy production, and the biosynthesis of nucleotides. The cellular response to L-glutamine begins with its uptake into the cell via the glutamine transporter. Once inside the cell, L-glutamine can be used for a variety of metabolic pathways. One of the most important pathways is the synthesis of glutamate, which is a precursor for the neurotransmitter GABA. Glutamine can also be used to synthesize other amino acids, such as proline and arginine. In addition, L-glutamine can be used as an energy source by the cell. It is broken down into alpha-ketoglutarate, which enters the Krebs cycle. The Krebs cycle is a central metabolic pathway that produces energy for the cell. L-glutamine also plays a role in the biosynthesis of nucleotides. It is used to synthesize the amino acids adenine and guanine, which are components of DNA and RNA. In addition, L-glutamine is involved in the regulation of cell growth and proliferation. It is important for the synthesis of proteins and DNA, both of which are essential for cell growth. The cellular response to L-glutamine is complex and involves a variety of metabolic pathways. It is essential for a wide range of cellular functions, including protein synthesis, energy production, and the biosynthesis of nucleotides. L-glutamine also plays a role in the regulation of cell growth and proliferation.'
"
Protein | Definition | Taxonomy |
---|---|---|
Heat shock factor protein 1 | A heat shock factor protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q00613] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
zm 336372 | N-(5-(3-dimethylaminobenzamido)-2-methylphenyl)-4-hydroxybenzamide: an inhibitor of c-Raf; activates Raf-1; structure in first source | benzamides | |
celastrol | monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory drug; antineoplastic agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; Hsp90 inhibitor; metabolite | |
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
chir-265 | aromatic ether | ||
az-628 | AZ-628: a multikinase inhibitor; structure in first source | benzamides | |
GDC-0879 | indanes; ketoxime; primary alcohol; pyrazoles; pyridines | antineoplastic agent; B-Raf inhibitor | |
plx4032 | aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor | |
dabrafenib | 1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide | anticoronaviral agent; antineoplastic agent; B-Raf inhibitor | |
tak-632 | TAK-632 : A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by (cyclopropanecarbonyl)amino, 4-fluoro-3-{2-[3-(trifluoromethyl)phenyl]acetamido}phenoxy, and cyano groups at positions 2, 6 and 7, respectively. It is a potent pan-RAF inhibitor with IC50 of 1.4, 2.4 and 8.3 nM for CRAF, BRAF(V600E), BRAF(WT), respectively. | (trifluoromethyl)benzenes; aromatic ether; benzothiazoles; cyclopropylcarboxamide; monofluorobenzenes; nitrile; secondary carboxamide | antineoplastic agent; apoptosis inducer; B-Raf inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; necroptosis inhibitor |
dinaciclib | pyrazolopyrimidine | ||
n2-(1h-indazole-5-yl)-n6-methyl-3-nitropyridine-2,6-diamine | KRIBB11 : A member of the class of indazoles that is 1H-indazole substituted by a [6-(methylamino)-3-nitropyridin-2-yl]amino group at position 5. It is an inhibitor of heat shock factor 1 (IC50 = 1.2muM) and suppresses tumour growth in mouse xenograft models. N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine: a heat shock factor 1 antagonist; structure in first source |